Literature DB >> 19503110

Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD.

R Rodriguez, A Nademanee, J M Palmer, P Parker, R Nakamura, D Snyder, V Pullarkat, J Zain, E Smith, F Sahebi, K Patane, D Senitzer, K Chang, S J Forman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19503110     DOI： 10.1038/bmt.2009.112

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.

Authors:  Zaid Al-Kadhimi; Zartash Gul; Roberto Rodriguez; Wei Chen; Daryn Smith; Alice Mitchell; Muneer Abidi; Lois Ayash; Abhinav Deol; Lawrence Lum; Stephen Forman; Voravit Ratanatharathorn; Joseph Uberti
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-16       Impact factor: 5.742

2.  A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant.

Authors:  S K Khaled; J Palmer; T Stiller; D Senitzer; R Maegawa; R Rodriguez; P M Parker; A Nademanee; J L Cai; D S Snyder; C Karanes; E Osorio; S H Thomas; S J Forman; R Nakamura
Journal:  Bone Marrow Transplant       Date:  2012-09-24       Impact factor: 5.483
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.